Both wild-type α-syn and α-syn with mutations known to be involved in human PD (A30P, A53T) have been suggested to interfere with the CRE-dependent regulation of DBH transcription in cultured norepinephrinergic cells [127] (Figure 3). This evidence concerns the gene DBH and Parkinson disease.